Effective infection, apoptotic cell killing and gene transfer of human hepatoma cells but not primary hepatocytes by parvovirus H1 and derived vectors

Cancer Gene Therapy

Volumn 8, Issue 3, 2001, Pages 158-167

  Moehler, Markus ^a   Blechacz, Boris ^b   Weiskopf, Nancy ^a   Zeidler, Maja ^a   Stremmel, Wolfgang ^b   Rommelaere, Jean ^c,d   Galle, Peter R ^a   Cornelis, Jan J ^c,d  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d Institut National de la Sante et de la Recherche Medicale U701   (Germany)

Author keywords

Apoptosis; Autonomous parvovirus; Hepatocellular carcinoma; Hepatocytes; Human

Indexed keywords

CASPASE INHIBITOR; VIRUS PROTEIN; VIRUS VECTOR;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER THERAPY; CELL STRAIN HEPG2; CONTROLLED STUDY; CYTOLYSIS; DNA REPLICATION; GENE THERAPY; GENE TRANSFER; HEPATOMA CELL; HUMAN; HUMAN CELL; INFECTION; LIVER CELL CARCINOMA; LIVER CELL CULTURE; NONHUMAN; PARVOVIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENE; TREATMENT INDICATION; VIRUS INFECTIVITY; VIRUS REPLICATION;

ANIMALIA; H1 VIRUS; PARVOVIRUS;

EID: 0035050285     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700288     Document Type: Article

References (47)

1. The increasing incidence of hepatocellular carcinoma
2. Treatment of hepatocellular carcinoma
3. Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival
4. Detection of adenovirus and initiation of apoptosis in hepatocellular carcinoma cells after Ad-p53 treatment
5. In vivo therapy of hepatocellular carcinoma with a tumor-specific adenoviral vector expressing interleukin-2
6. Complete cure of established murine hepatocellular carcinoma is achievable by repeated injections of retroviruses carrying the herpes simplex virus thymidine kinase gene
7. Gene therapy for hepatocellular carcinoma: Chemosensitivity conferred by adenovirus-mediated transfer of the HSV-1 thymidine kinase gene
8. Gene therapy of hepatocellular carcinoma in vitro and in vivo in nude mice by adenoviral transfer of the Escherichia coli purine nucleoside phosphorylase gene
9. Complete regression of established murine hepatocellular carcinoma by in vivo tumor necrosis factor alpha gene transfer
10. Gene therapy of liver tumors: Principles and applications
11. Liver-directed gene therapy: Molecular tools and current preclinical and clinical studies
12. Antineoplastic activity of parvoviruses
13. Parvoviridae: The viruses and their replication
14. Rodent parvoviruses infections
15. Phase I clinical study on the possible use of H1 parvovirus in cancer treatment
16. Programmed killing of human cells by means of an inducible clone of parvoviral genes encoding nonstructural proteins
17. The cytotoxicity of the autonomous parvovirus minute virus of mice nonstructural proteins in FR3T3 rat cells depends on oncogene expression
18. Induction of programmed cell death by parvovirus H1 in U937 cells: Connection with the TNF-α signalling pathway
19. Induction of apoptosis in vitro and in vivo by H1 parvovirus infection
20. Ultrastructural features of fetal erythroid precursors infected with parvovirus B19 in vitro: Evidence of cell death by apoptosis
21. Human parvovirus B19 nonstructural (NS1) protein induces apoptosis in erythroid lineage cells
22. Selective killing of simian virus 40-transformed human fibroblasts by parvovirus H1
23. Transformation of human fibroblasts by ionizing radiation, a chemical carcinogen or simian virus 40 correlates with an increase in susceptibility to the autonomous parvoviruses H1 virus and minute virus of mice
24. Inhibition by parvovirus H1 of the formation of tumors in nude mice and colonies in vitro by transformed human mammary epithelial cells
25. Dose-dependent regression of HeLa cell-derived tumors in SCID mice after parvovirus H1 infection
26. A model of tumor suppression using H1 parvovirus
27. Parvovirus H1 inhibits growth of short-term tumor-derived but not normal mammary tissue cultures
28. Inhibitory effect of parvovirus H1 on cultured human tumor cells or transformed cells
29. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53
30. In vitro experimental infection of primary human hepatocytes with hepatitis B virus
31. Cis requirements for the efficient production of recombinant DNA vectors based on autonomous parvoviruses
32. Isolation of a fully infectious variant of parvovirus H1 supplanting the standard strain in human cells
33. Recombinant LuIII autonomous parvovirus as a transient transducing vector for human cells
34. Flow cytometry of apoptotic cell death
35. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage
36. pH-independent uptake of hepatitis B virus in primary human hepatocytes
37. CD95-induced apoptosis in human liver disease
38. Hepatitis B virus infection of adult human hepatocytes cultured in the presence of dimethyl sulfoxide
39. Cyclin A activates the DNA polymerase D-dependent elongation machinery in vitro: A parvovirus DNA replication model
40. Transformation-dependent expression of interleukin genes delivered by a recombinant parvovirus
41. Tumor-selective gene transduction and cell killing with an oncotropic autonomous parvovirus-based vector
42. Highly efficient transduction and expression of cytokine genes in human tumor cells by means of autonomous parvovirus vectors; generation of antitumor responses in recipient mice
43. p53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the codon 249 hot spot mutation
44. The significance of p53 mutations as an indicator of the biological behavior of recurrent hepatocellular carcinomas
45. Expression of p53 gene in 184 unifocal hepatocellular carcinomas: Association with tumor growth and invasiveness
46. Role of oncogenes in resistance and killing by cancer therapeutic agents
47. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells. A mechanism of immune evasion?